Depression Treatments for Pancreatitis
Seroquel has been known to be the leading powerful medication for the treatment of different kinds of mental illness including schizophrenia, bipolar disorder, and depression. However, did you know that depression treatments for pancreatitis manifestation is possible?
A federal lawsuit filed during the year 2006 alleged that Seroquel can cause the development of pancreatitis. It is a disease characterized by the inflammation of one of your vital organs called the pancreas. This organ is responsible in the production of digestive enzymes as well as insulin, which help regulate your blood sugar. When the pancreas gets damaged, it can be life threatening and promote the development of gastrointestinal disorders. Normally, there is damage to your tissues as well as internal bleeding. You may also be susceptible to different forms of infection. There are also patients who develop pseudocysts. Tissue debris and fluid accumulate until they become very toxic.
The complaint stated that the AstraZeneca, makers of Seroquel, didn't provide consumer warning with regards to the big risks involved in taking in Seroquel, such as fatal injuries to important body organs like the pancreas, liver, and kidney.
There are many complications associated with pancreatitis. For one, it can create breathing problems in which your body cells and tissues do not get sufficient oxygen. Failure to be given proper treatment can cause failure in your lungs or you will be dependent on a ventilator. Preventing the development of pancreatitis is therefore very important; this includes avoiding depression treatments for pancreatitis. You should also need to refer to your doctor.
Charlene J. Nuble is a healthcare professional who loves writing about women's issues, parenting and other health related stuffs. Click on the link to learn more about Depression Treatments for Pancreatitis...
Source: http://ezinearticles.com/
Added: April 25, 2008
Eli Lilly's ImClone Deal Adds Risk - Barron's
The Associated Press Eli Lilly's ImClone Deal Adds Risk Barron's - Although Byetta (and the GLP-1 category) could be big, controversies surrounding competitor dynamics and pancreatitis risk for the class should persist over ... Amylin Buyout Unlikely To Materialize Anytime Soon